Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Soiken Holdings Inc
2385Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for pharmaceutical clinical research and epidemiology studies; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. The company was incorporated in 1994 and is headquartered in Toyonaka, Japan. Address: Senri Life Science Center, Toyonaka, Japan, 560-0082
Analytics
Precio Objetivo de WallStreet
93 431.85 JPYRelación P/E
–Rentabilidad por dividendo
3.66 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave 2385
Análisis de dividendos 2385
Aumento del dividendo durante 5 años
150 %Crecimiento continuo
–Ratio de pago medio en 5 años
20 %Tendencia del payout 2385
Valoración de la acción 2385
Finanzas 2385
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |